FDA — authorised 6 April 2012
- Application: NDA202008
- Marketing authorisation holder: AVID RADIOPHARMS INC
- Status: supplemented
FDA authorised Amyvid on 6 April 2012
Yes. FDA authorised it on 6 April 2012; FDA has authorised it.
AVID RADIOPHARMS INC holds the US marketing authorisation.